Possible scandal at Pfizer, involving rep promotion and CME programs – overview here, and interview with internal whistleblower here. Lesson: it really isn’t worth skirting around the edges – reporting this stuff is now far too easy, and covering it up just ain’t going to work.
Indevus gets once-daily version of Sanctura (overactive bladder drug) approved.
The spreading job cuts among pharma companies.
Cause for Rosacea found? Very interesting news for those in derm.